Literature DB >> 11003411

Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography.

J P Laissy1, D Menegazzo, M P Debray, M Toublanc, V Ravery, E Dumont, E Schouman-Claeys.   

Abstract

The aim of this study was to evaluate the usefulness of gadolinium-enhanced time-of-flight magnetic resonance venography (MRV) in the diagnosis of bland thrombosis/tumoral invasion in the preoperative assessment of renal cell carcinoma. Preoperative precontrast and enhanced GRE fast lowangle shot (FLASH) images of 36 patients with renal adenocarcinoma were reviewed and compared with pre- and post-contrast T1-weighted images. All patients underwent surgery, and MR findings were blindly and prospectively compared with surgical and pathologic data, considered the standard. Renal vein and vena cava were involved in 17 and 9 patients, respectively; right atrial extension was present in one patient. Precontrast spin-echo (SE) and FLASH images were 88% sensitive and 100% specific in the detection of venous involvement, respectively, and enhanced FLASH images 100% sensitive and 96% specific. The nature of thrombus (neoplastic or bland) was more accurately assessed (McNemar's, p < 0.05) with FLASH-enhanced MR images (sensitivity 89%; specificity 96%) than with SE and precontrast FLASH images (sensitivity 79%; specificity 94%). Our data suggest that use of Gd-enhanced MRV might improve preoperative assessment of vascular involvement in renal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003411     DOI: 10.1007/s003309900296

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

Review 1.  Imaging renal cell carcinoma with ultrasonography, CT and MRI.

Authors:  Michael J Leveridge; Peter J Bostrom; George Koulouris; Antonio Finelli; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-05-18       Impact factor: 14.432

2.  [Evaluating inferior vena cava wall invasion in renal cell carcinoma tumor thrombus with MRI].

Authors:  J Y Wu; Y Mi; S Liu; L Yao; Q Tang; Z S He; X Y Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

3.  Preoperative Prediction of Inferior Vena Cava Wall Invasion of Tumor Thrombus in Renal Cell Carcinoma: Radiomics Models Based on Magnetic Resonance Imaging.

Authors:  Zhaonan Sun; Yingpu Cui; Chunru Xu; Yanfei Yu; Chao Han; Xiang Liu; Zhiyong Lin; Xiangpeng Wang; Changxin Li; Xiaodong Zhang; Xiaoying Wang
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

4.  Intraoperative detection of inferior vena caval tumor thrombus extending from metastatic lymph node of renal cell carcinoma using ultrasonography.

Authors:  Tomonori Minagawa; Daisuke Fukui; Kunihiko Shingu; Teruyuki Ogawa; Kenji Okada; Osamu Ishizuka
Journal:  J Med Ultrason (2001)       Date:  2017-10-27       Impact factor: 1.314

Review 5.  MRI of the kidney-state of the art.

Authors:  J J Nikken; G P Krestin
Journal:  Eur Radiol       Date:  2007-07-24       Impact factor: 5.315

Review 6.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

7.  CT/MRI in staging renal cell carcinoma.

Authors:  Rodney H Reznek
Journal:  Cancer Imaging       Date:  2004-02-14       Impact factor: 3.909

8.  Detection, staging and surveillance in renal cell carcinoma.

Authors:  Isaac R Francis
Journal:  Cancer Imaging       Date:  2006-11-08       Impact factor: 3.909

Review 9.  Surgical management of renal cell carcinoma invading the vena cava.

Authors:  Matthew T Gettman; Michael L Blute
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

10.  Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.

Authors:  Lisa C Adams; Bernhard Ralla; Yi-Na Y Bender; Keno Bressem; Bernd Hamm; Jonas Busch; Florian Fuller; Marcus R Makowski
Journal:  Cancer Imaging       Date:  2018-05-03       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.